Mechanisms of DJ-1 Protection against methamphetamine neurotoxicity.

DJ-1 预防甲基苯丙胺神经毒性的机制。

• 批准号: 8048849
• 负责人: JEAN-CHRISTOPHE ROCHET
• 金额: $ 7.21万
• 依托单位: PURDUE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8048849
• 关键词: 1-Phosphatidylinositol 3-Kinase; Address; Adenoviruses; Antioxidants; Astrocytes; Brain; Cell Death; Cell Nucleus; Cells; Characteristics; Cytosol; DNA; Data; Development; Disease model; Engineering; Exhibits; Foundations; Functional disorder; Genetic Transcription; Goals; Human; Immunofluorescence Microscopy; Impairment; Individual; Intervention; Measures; Mediating; Methamphetamine; Microglia; Midbrain structure; Mitochondria; Molecular Chaperones; Monitor; Nerve Degeneration; Neurites; Neuroglia; Neurons; Oxidative Stress; PARK7 protein; Parkinson Disease; Pathology; Pathway interactions; Patients; Pharmaceutical Preparations; Phenotype; Play; Positioning Attribute; Process; Proteins; Research; Role; Signal Transduction; Stress; Symptoms; Time; Toxic effect; Tropism; Up-Regulation; Variant; Virus; alpha synuclein; cell type; design; dopaminergic neuron; improved; insight; loss of function; methamphetamine abuse; mitochondrial dysfunction; motor deficit; multicatalytic endopeptidase complex; neuron loss; neurotoxic; neurotoxicity; nigrostriatal system; oxidative damage; prevent; promoter; protein expression; response; small hairpin RNA; synuclein; therapeutic development

DESCRIPTION (provided by applicant): Methamphetamine induces dopaminergic neurite degeneration, oxidative damage, and a-synuclein (aSyn) aggregation in the nigrostriatal system. Similar neuropathological features are evident in the brains of individuals with Parkinson's disease (PD). Familial and sporadic PD involve dysfunction of DJ-1, a neuroprotective protein that suppresses oxidative stress and aSyn aggregation by activating various pro- survival mechanisms. Collectively, these observations suggest that DJ-1 may protect against methamphetamine neurotoxicity. The long-term objective of the proposed research is to identify cellular responses that abrogate dopaminergic neurite degeneration elicited by methamphetamine, as a way to stimulate the discovery of new therapies. The studies described in this application are focused on the role of DJ-1 in alleviating methamphetamine neurotoxicity. This question will be addressed with the following specific aims: (i) determine whether DJ-1 inhibits methamphetamine-induced neurite loss; (ii) assess whether DJ-1 suppresses oxidative stress and 1-synuclein aggregation in methamphetamine-treated cells; and (iii) determine whether DJ-1-mediated protection against methamphetamine neurotoxicity requires expression of the protein in glia and/or neurons. Primary midbrain cultures expressing human wild-type DJ-1 from an adenoviral construct will be exposed to methamphetamine, and the percentage of dopaminergic neurons without processes will be determined immunocytochemically. The cells will also be characterized in terms of a range of DJ-1 protective responses. The effect of subcellular localization will be investigated by measuring the neuroprotective activity of engineered DJ-1 variants preferentially targeted to the cytosol, mitochondria, or nucleus. The role of cell-type-specific DJ-1 expression will be examined by monitoring protective pathways in cultures that express DJ-1 selectively in neurons, astrocytes, or microglia. This project will advance our understanding of cellular responses that alleviate methamphetamine neurotoxicity. Ultimately, the insights from this study will stimulate the development of strategies to treat individuals exposed to methamphetamine via activation of neuroprotective pathways modulated by DJ-1. PUBLIC HEALTH RELEVANCE: This project is designed to assess neuroprotective mechanisms by which the protein DJ-1 suppresses the loss of neuronal processes triggered by methamphetamine. The insights from these studies will stimulate the development of therapeutic strategies to alleviate methamphetamine neurotoxicity via upregulation of DJ-1 protective responses.

描述（由申请人提供）：甲基苯丙胺诱导黑质纹状体系统中的多巴胺能神经突变性、氧化损伤和α-突触核蛋白（aSyn）聚集。类似的神经病理学特征在帕金森病 (PD) 患者的大脑中也很明显。家族性和散发性 PD 涉及 DJ-1 的功能障碍，DJ-1 是一种神经保护蛋白，通过激活各种促生存机制来抑制氧化应激和 aSyn 聚集。总的来说，这些观察结果表明 DJ-1 可以防止甲基苯丙胺的神经毒性。拟议研究的长期目标是确定消除甲基苯丙胺引起的多巴胺能神经突变性的细胞反应，作为刺激新疗法发现的一种方式。本申请中描述的研究重点是 DJ-1 在减轻甲基苯丙胺神经毒性中的作用。该问题将通过以下具体目标来解决：（i）确定 DJ-1 是否抑制甲基苯丙胺诱导的神经突损失； (ii) 评估 DJ-1 是否抑制甲基苯丙胺处理的细胞中的氧化应激和 1-突触核蛋白聚集； (iii)确定DJ-1介导的针对甲基苯丙胺神经毒性的保护是否需要该蛋白在神经胶质细胞和/或神经元中表达。从腺病毒构建体表达人野生型DJ-1的原代中脑培养物将暴露于甲基苯丙胺，并且将通过免疫细胞化学测定无突的多巴胺能神经元的百分比。这些细胞还将根据一系列 DJ-1 保护反应进行表征。将通过测量优先靶向细胞质、线粒体或细胞核的工程化 DJ-1 变体的神经保护活性来研究亚细胞定位的效果。将通过监测在神经元、星形胶质细胞或小胶质细胞中选择性表达 DJ-1 的培养物中的保护途径来检查细胞类型特异性 DJ-1 表达的作用。该项目将增进我们对减轻甲基苯丙胺神经毒性的细胞反应的理解。最终，这项研究的见解将刺激开发策略，通过激活 DJ-1 调节的神经保护途径来治疗暴露于甲基苯丙胺的个体。 公共健康相关性：该项目旨在评估 DJ-1 蛋白抑制甲基苯丙胺引发的神经元过程丧失的神经保护机制。这些研究的见解将刺激治疗策略的发展，通过上调 DJ-1 保护反应来减轻甲基苯丙胺的神经毒性。